Intuitive Surgical (ISRG)
Builds robotic surgical and lung-biopsy platforms with procedure-linked instruments and service.
$397.64
vs last close−4.45 (−1.11%)
Something off on this page? Send us feedback.
Next report
Oct 20, 26
in 27 days
EPS estimate
$2.64
Revenue estimate
$2.91B
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$2.21$1.81$2.19$2.40$2.53$2.80$2.80Pending
Estimate$1.76$1.74$1.93$1.99$2.27$2.51$2.48$2.64
Surprise+25.6%+4.0%+13.5%+20.6%+11.5%+11.6%+12.9%—
RevenueReportedEstimate
Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$2.41B$2.25B$2.44B$2.51B$2.87B$2.77B$2.89BPending
Estimate$2.25B$2.19B$2.35B$2.41B$2.76B$2.62B$2.83B$2.91B
Surprise+7.3%+3.1%+3.8%+4.1%+3.7%+5.8%+2.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $3.51 | — | — |
| Sep 2028 | $3.33 | — | — |
| Jun 2028 | $3.29 | — | — |
| Mar 2028 | $2.87 | — | — |
| Dec 2027 | $3.23 | — | — |
| Sep 2027 | $3.02 | — | — |
| Jun 2027 | $3.03 | — | — |
| Mar 2027 | $2.74 | — | — |
| Dec 2026 | $2.85 | — | — |
| Oct 2026 | $2.64 | — | — |
| Jul 2026 | $2.48 | $2.80 | +12.9% |
| Apr 2026 | $2.51 | $2.80 | +11.6% |
| Jan 2026 | $2.27 | $2.53 | +11.5% |
| Oct 2025 | $1.99 | $2.40 | +20.6% |
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Jan 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Jan 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Jan 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Oct 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $3.51 | — | — | $3.98B | — | — | — |
| Sep 2028 | $3.33 | — | — | $3.66B | — | — | — |
| Jun 2028 | $3.29 | — | — | $3.56B | — | — | — |
| Mar 2028 | $2.87 | — | — | $3.38B | — | — | — |
| Dec 2027 | $3.23 | — | — | $3.62B | — | — | — |
| Sep 2027 | $3.02 | — | — | $3.29B | — | — | — |
| Jun 2027 | $3.03 | — | — | $3.25B | — | — | — |
| Mar 2027 | $2.74 | — | — | $3.13B | — | — | — |
| Dec 2026 | $2.85 | — | — | $3.21B | — | — | — |
| Oct 20, 2026 | $2.64 | — | — | $2.91B | — | — | — |
| Jul 16, 2026 | $2.48 | $2.80 | +12.9% | $2.83B | $2.89B | +2.4% | +3.4% |
| Apr 21, 2026 | $2.51 | $2.80 | +11.6% | $2.62B | $2.77B | +5.8% | +7.2% |
| Jan 22, 2026 | $2.27 | $2.53 | +11.5% | $2.76B | $2.87B | +3.7% | −0.4% |
| Oct 21, 2025 | $1.99 | $2.40 | +20.6% | $2.41B | $2.51B | +4.1% | +13.9% |
| Jul 22, 2025 | |||||||
| Apr 22, 2025 | |||||||
| Jan 23, 2025 | |||||||
| Oct 17, 2024 | |||||||
| Jul 18, 2024 | |||||||
| Apr 18, 2024 | |||||||
| Jan 23, 2024 | |||||||
| Oct 19, 2023 | |||||||
| Jul 20, 2023 | |||||||
| Apr 18, 2023 | |||||||
| Jan 24, 2023 | |||||||
| Oct 18, 2022 | |||||||
| Jul 21, 2022 | |||||||
| Apr 21, 2022 | |||||||
| Jan 20, 2022 | |||||||
| Oct 19, 2021 | |||||||
| Jul 20, 2021 | |||||||
| Apr 20, 2021 | |||||||
| Jan 21, 2021 | |||||||
| Oct 15, 2020 | |||||||
| Jul 21, 2020 | |||||||
| Apr 16, 2020 | |||||||
| Jan 23, 2020 | |||||||
| Oct 17, 2019 | |||||||
| Jul 18, 2019 | |||||||
| Apr 18, 2019 | |||||||
| Jan 24, 2019 | |||||||
| Oct 18, 2018 | |||||||
| Jul 19, 2018 | |||||||
| Apr 17, 2018 | |||||||
| Jan 25, 2018 | |||||||
| Oct 19, 2017 | |||||||
| Jul 20, 2017 | |||||||
| Apr 18, 2017 | |||||||
| Jan 24, 2017 | |||||||
| Oct 18, 2016 | |||||||
| Jul 19, 2016 | |||||||
| Apr 19, 2016 | |||||||
| Jan 21, 2016 | |||||||
| Oct 20, 2015 | |||||||
| Jul 21, 2015 |